Swine
flu vaccine linked to narcolepsy
Children
who had narcolepsy were 14 times more likely to have been vaccinated
with Pandemrix than other children in England of the same age.
27
January, 2013
Children
in England who were given a version of the swine flu vaccine between
2009 and 2010 were at increased risk of developing narcolepsy after
they got the shot, a new study suggests.
The
findings are similar to those of previous studies conducted in
Finland and Sweden, which also found a link between the 2009 swine
flu vaccine called Pandemrix (made by GlaxoSmithKline) and narcolepsy
in children.
However,
because a large number of people were vaccinated and narcolepsy is
rare, a child's chances of developing the disorder following
vaccination were extremely small, around 1 in 55,000. What's more,
these studies still show only an association and cannot prove the
vaccine caused narcolepsy.
Pandemrix
was administered to about 30 million people in Europe, but was not
used in the United States. The vaccine has not been used in young
people since July 2011, the researchers said.
Narcolepsy
is a sleep disorder characterized by excessive sleepiness during the
daytime and, sometimes, temporary muscle weakness, paralysis while
falling asleep or waking, and hallucinations, according to the Mayo
Clinic. The cause is not known, but it most often begins in children
ages 10 to 19.
Because
of the link between Pandemrix and narcolepsy seen in other European
countries, a study looking into the issue in England began in
February 2011. Elizabeth Miller, a consultant epidemiologist at the
United Kingdom's Health Protection Agency, and colleagues analyzed
information on 245 children and teens who visited sleep centers in
England. Seventy-five of the children had developed narcolepsy after
January 2008. Of these, 11 had been vaccinated with Pandemrix before
their symptoms started, and 7 had been vaccinated within 6 months of
the onset of their symptoms.
Children
who had narcolepsy were 14 times more likely to have been vaccinated
with Pandemrix than other children in England of the same age. The
English results are similar to those of a 2012 study from Finland,
which found a 13-fold increase in the risk of narcolepsy following
vaccination for children in that country.
Narcolepsy
can be difficult to identify, and it can take years before a person
with symptoms visits the doctor and receives a diagnosis. News from
Finland and Sweden about the link between the swine flu vaccine and
narcolepsy may have made British parents more aware of the signs of
the disorder in their children, and thus made parents more likely to
seek care for their child's problem. If this is the case, the risk of
narcolepsy following vaccination in England could have been
overestimated, the researchers said.
Although
studies like these can't prove Pandemrix caused narcolepsy, "the
evidence is adding up to suggest that there is a small increased risk
of narcolepsy," after vaccination, said Dr. Andy Pavia, chief of
the University of Utah's Division of Pediatric Infectious Diseases,
who was not involved in the study. Earlier research has found that
the risk is higher among people with a particular genetic marker,
Pavia said.
The
Pandemrix vaccine contains an adjuvant called ASO3. (An adjuvant is
an ingredient added to a vaccine to boost its effects). So far, only
Pandemrix, which mixes ASO3 with the 2009 pandemic H1N1 flu vaccine,
has been linked to an increased risk of narcolepsy. Other flu
vaccines and other vaccines that contain ASO3 have not been linked to
the condition, Pavia said.
Dr.
Paul Offit, chief of the Division of Infectious Diseases at the
Children's Hospital of Philadelphia, agreed that a link between swine
flu vaccination and narcolepsy exists, but only if three things
happen at once: the vaccine contains the 2009 pandemic H1N1 flu
strain; the vaccine contains ASO3, and the person being vaccinated
has a genetic susceptibility to narcolepsy.
The
fact that these three factors need to converge makes the development
of narcolepsy following vaccination a rare event. "The risk of
being hospitalized or killed by [flu] is greater than the risk of
narcolepsy," Offit said.
Although
doctors don't know what causes narcolepsy, some studies have linked
the condition to certain infections, for example, by the bacterium
Streptococcus, said Dr. Sheila Tsai, a sleep expert at the National
Jewish Health Center in Denver. It has been hypothesized that an
immune system reaction may be one trigger of narcolepsy, but
scientists don't know for sure if this is what's happening, Tsai
said.
The
new study was published on Feb. 26 in the British Medical Journal.
Early results from the study were reported last month by Reuters.
To
watch video GO
HERE
Dexamphetamine is an amphetamine-based psychostimulant that has been used as a Treatment for Narcolepsy for many years. It comes in 5mg tablets and can be used at doses of up to 60mg every day.
ReplyDelete